JARDIN is created to improve the accessibility of the ERNs for people living with rare diseases or complex conditions in EU member states.
Company Details
- Employees
- 5
- Industry
- Public Health
- NAICS
-
Administration of Public Health Programs
- Website
- https://jardin-ern.eu/
- Keywords
- Rare Diseases, Health, ERN, European Reference Networks, Complex diseases, EU health, European Reference Networks, Complex conditions.
- Competitors
- ERN TransplantChild, EURACAN, ERN EpiCARE - Rare and Complex Epilepsies, Telethon Institute of Genetics and Medicine (TIGEM), EURORDIS-Rare Diseases Europe, Innovative Health Initiative (IHI), ERDERA, Alliance maladies rares, Orphanet, EFPIA - European Federation of Pharmaceutical Industries and Associations.
Jardin Joint Action Questions
Jardin Joint Action's website is https://jardin-ern.eu/
Jardin Joint Action's LinkedIn profile is https://www.linkedin.com/company/jardin-joint-action
Jardin Joint Action has
5 employees.
View email and phone details for 5
employees at Jardin Joint Action.
Jardin Joint Action's industry is
Public Health
Jardin Joint Action's top competitors are
Ern Transplantchild,
Euracan,
Ern Epicare - Rare And Complex Epilepsies,
Telethon Institute Of Genetics And Medicine (Tigem),
Eurordis-Rare Diseases Europe,
Innovative Health Initiative (Ihi),
Erdera,
Alliance Maladies Rares,
Orphanet,
Efpia - European Federation Of Pharmaceutical Industries And Associations.
Jardin Joint Action's categories are Public Health
